Relevance of the pharmacokinetic profile in the treatment of angina pectoris: the need for 24 h control.
Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.
J
J
Tamargo
J
J
López-Sendón
D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D017202:Myocardial Ischemia / Q000378:metabolism
D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents